<DOC>
	<DOCNO>NCT02042560</DOCNO>
	<brief_summary>This multicentre , open , case/control study aim investigate quantitative functional manner different population immune cell auto-immune thrombopenia : 1 . Disturbed T lymphocyte response 1 . TH1 response predominant TH2 response 2 . Implication TH17 L 3 . Quantitative and/or functional deficit regulatory T L 4 . Involvement anti-apoptotic mechanism TL 2 . Disturbed B lymphocyte response 1 . Hyperactivation B lymphocytes involvement memory BL 2 . Secretion autoantibodies 3 . Implication ImC disturbance pDC/mDC ratio 4 . Study splenic immune cell ( TL , BL , DC ) The study way modify investigation procedure ( diagnostic therapeutic strategy ) , carry usual . Blood sample relate study take context pathology investigation require additional puncture . Spleen sample obtain consent patient therapeutic splenectomy plan , usually propose patient ITP .</brief_summary>
	<brief_title>Physiopathology Study Auto-immune Thrombopenia . Multicentre , Open , Controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<criteria>person provide write informed consent patient group : patient ITP ( define thrombopenia &lt; 30 000/mm3 , cause related infection , medication , autoimmune disease malignant hemopathy eliminate ) control group : person provide write informed consent meet exclusion criterion person without national health insurance cover person less 18 year old patient guardianship ward court pregnant woman control group : subject present autoimmune disease , cancer , progressive infection , treat corticoid immunosuppressant include control .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>